Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1B, Multicenter, Open-Label Study of the Safety and Efficacy of CHS-114 in Combination With Toripalimab With or Without Other Treatments in Participants With Advanced or Metastatic Solid Tumors (TREGCHECK 102)

NCT06657144 is registered in ClinicalTrials.gov with Coherus Oncology, Inc. as lead sponsor.

NCT NCT06657144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06657144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1B, Multicenter, Open-Label Study of the Safety and Efficacy of CHS-114 in Combination With Toripalimab With or Without Other Treatments in Participants With Advanced or Metastatic Solid Tumors (TREGCHECK 102)
Lead sponsor
Coherus Oncology, Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
April 1, 2025
Completion date
January 31, 2028
Enrollment
154 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor, metastatic solid tumor